Overall rank by patents
#2,126
Across all tracked assignees
USPTO PatentsView assignee record - 185 granted patents across 49 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
Boehringer holds 185 US patents across 49 technology areas, rank #2,126 of 50,000 tracked assignees.
Boehringer Ingelheim Vetmedica Gmbh has been granted 185 US utility patents between 2015 and 2025, placing Boehringer Ingelheim Vetmedica Gmbh at rank #2,126 across all assignees tracked by PlainPatent. This portfolio spans 49 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.0 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Boehringer Ingelheim Vetmedica Gmbh is one of the more focused assignees in the PatentsView dataset. By volume, Boehringer sits between Tanaka Kikinzoku Kogyo K.k. (186 patents, rank #2,122) and National Taiwan University Of Science And Technology (185 patents, rank #2,130) - the closest US assignees by grant volume. The composite Innovation Score of 56.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 62 grants, compared with 123 in the 2015–2019 window, a -50% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Boehringer Ingelheim Vetmedica Gmbh's 18.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 49 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Boehringer Ingelheim Vetmedica Gmbh against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
TANAKA KIKINZOKU KOGYO K.K.
186 patents
The Chamberlain Group LLC
186 patents
University of Hong Kong
186 patents
Advanced Energy Industries, Inc.
185 patents
Canon Anelva Corporation
185 patents
Cooler Master Co., Ltd.
185 patents
FUJITSU SEMICONDUCTOR LIMITED
185 patents
National Taiwan University of Science and Technology
185 patents
BOEHRINGER INGELHEIM VETMEDICA GMBH
185 patents
What this shows Boehringer holds 185 patents at rank #2,126, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,126 in granted patent volume.
Other assignees with the most granted patents in Boehringer's primary technology class.
Boehringer's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
56 Top 6% higher than 94% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 27 | 14.6% |
| 2016 | 21 | 11.4% |
| 2017 | 25 | 13.5% |
| 2018 | 36 | 19.5% |
| 2019 | 14 | 7.6% |
| 2020 | 20 | 10.8% |
| 2021 | 17 | 9.2% |
| 2022 | 8 | 4.3% |
| 2023 | 6 | 3.2% |
| 2024 | 6 | 3.2% |
| 2025 | 5 | 2.7% |
Top 15 of 49 technology areas
Overall rank by patents
#2,126
Across all tracked assignees
56.2 out of 100
How to use this portfolio
Boehringer's 185 grants land it in the top 6% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.